May 8, 2018 comslyndra

About Us

Company Timeline

2015
2015

Company Founded

Founded on technology developed within the Massachusetts Institute of Technology laboratory of Dr. Robert Langer in collaboration with the Bill & Melinda Gates Foundation
2016
2016

Preclinical Proof of Concept

Platform and single agent preclinical in 2 species - ($0.3 M NIH Grant)
2017
2017

First in Human Proof of Concept

Demonstrated gastric residence achievable with desired pharmacokinetics-single agent -  ($23 M Series A, $105 M AbbVie Partnership, $6 M NIH Grant(s), $4 M BMGF Grant)
                
2018
2018

Clinical Phase 1 Studies

Demonstrated once-weekly dosage form can safely reside in the stomach with predictable pharmacokinetics - single agent - ($18 M NIH Grant(s), $13 M BMGF Grant)

    
2019
2019

Expanded Phase 1 Pipeline

Demonstrated once-weekly dosage form can safely reside in the stomach with predictable pharmacokinetics - two agents in one capsule and preliminary food effects - ($60 M Series B, $122 M Gilead Partnership, $19M NIH Grant, $3 M DoD Grant)
             
        
2020
2020

Initiate Phase 2 Clinical Studies and Established GMP Manufacturing

team

HurterHeadshot

Dr Patricia Hurter

CEO | President | Member of the Board
Jess

Jessica Ballinger

Chief Operations Officer
Ray

Raymond Knox

Chief Manufacturing Officer
Richard 2

Dr Richard Scranton

Chief Medical Officer
Orn

Dr Örn Almarsson

Chief Technology Officer
Picture1

George Eldridge

Chief Financial Officer
Mary Thumbnail

Dr Mary Christian

SVP, Regulatory, Quality & Compliance
Tyler

Dr Tyler Grant

Sr Director, Engineering
Rose

Dr Rosemary Kanasty

Director, Platform Discovery

Board of Directors

Catherine Reynolds 2020 BW

Catherine B. Reynolds

Chair of the Board
amy

Amy Schulman

Executive Chair of the Board | Co-Founder
HurterHeadshot

Dr Patricia Hurter

CEO | President | Member of the Board
Zafi

Dr Zafrira Avnur

Member of the Board
Robert_Langer_BioTech_Awards_Video_laboratory (1) a

Dr Robert Langer

Co-Founder | Member of the Board
Gio Traverso

Dr Giovanni Traverso

Co-Founder| Member of the Board

Company advisors

ANDREW_2313

Dr Andrew Bellinger

Co-Founder | Advisor
Bernie-2

Dr Bernard Silverman

Advisor
Ed Harrigan a

Dr Edmund Harrigan

Advisor
0

Dr Ian Wilding

Advisor
0 (2)

Dr Thomas Laughren

Advisor
Joga

Dr Joga Gobburu

Advisor
olanoff

Dr Lawrence Olanoff

Advisor
0 (3)

Dr Charles Beasley

Advisor
Peter

Dr Peter Belafsky

Advisor